THE LATEST IN Human C-Reactive Protein (CRP) Research:
Transgenic expression of human C-Reactive Protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury .These in vivo observations support the hypothesis that C-reactive Protein modulates NO metabolism and may have implications regarding the mechanisms by which CRP modulates vascular disease. Source: Am J Physiol Heart Circ Physiol 293: H489-H495, 2007
human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis. human C-Reactive Protein also enhanced myeloma cell secretion of IL-6 and synergized with IL-6 to protect myeloma cells from chemotherapy drug-induced apoptosis. Thus, our results implicate CRP as a potential target for cancer treatment.Source: Cancer Cell, Vol 12, 252-265, 11 September 2007
